Pathophysiology and significance of natriuretic peptides in patients with end-stage kidney disease
- 1 September 2020
- journal article
- review article
- Published by Elsevier in Clinical Biochemistry
- Vol. 83, 1-11
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Markers of Decongestion, Dyspnea Relief, and Clinical Outcomes Among Patients Hospitalized With Acute Heart FailureCirculation: Heart Failure, 2013
- B-type natriuretic peptide and interdialytic fluid retention are independent and incremental predictors of mortality in hemodialysis patientsClinical Nephrology, 2011
- NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patientsNephrology Dialysis Transplantation, 2009
- B-Type Natriuretic Peptide (BNP)/NT-proBNP and Renal Function: Is the Controversy Over?Clinical Chemistry, 2009
- Brain natriuretic peptide levels have diagnostic and prognostic capability for cardio-renal syndrome type 4 in intensive care unit patientsCritical Care, 2009
- Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patientsEuropean Heart Journal, 2008
- Amino-Terminal Pro–B-Type Natriuretic Peptides and Prognosis in Chronic Heart FailureThe American Journal of Cardiology, 2008
- Relationships of N-Terminal Pro–B-Natriuretic Peptide and Cardiac Troponin T to Left Ventricular Mass and Function and Mortality in Asymptomatic Hemodialysis PatientsAmerican Journal of Kidney Diseases, 2007
- Impact of Renal Disease on Natriuretic Peptide Testing for Diagnosing Decompensated Heart Failure and Predicting MortalityClinical Chemistry, 2007
- Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysisNephrology Dialysis Transplantation, 2007